Publications (38)

¹ Publications considered as the group’s output.

filter_list

2025

  1. Development of two indirect ELISAs using purified recombinant viral proteins to detect myxoma virus-antigen specific antibodies in rabbit sera

    BMC Veterinary Research, Vol. 21, Núm. 1

  2. Epidemiological surveillance of myxoma virus in European hares (Lepus europaeus) in the Iberian Peninsula: First evidence of infection by the emerging ha-MYXV

    Veterinary Microbiology, Vol. 302

  3. Epitope mapping of a neutralizing antibody against rabbit hemorrhagic disease virus GI.2

    Veterinary research, Vol. 56, Núm. 1, pp. 74

2024

  1. Highs and Lows in Calicivirus Reverse Genetics

    Viruses, Vol. 16, Núm. 6

  2. Kaposi’s sarcoma herpesvirus exploits the DNA damage response to circularize its genome

    Nucleic Acids Research, Vol. 52, Núm. 4, pp. 1814-1829

2023

  1. Prediction of Linear B Cell Epitopes in Proteins

    Methods in molecular biology (Clifton, N.J.), Vol. 2673, pp. 189-196

  2. The chaperone ClpC participates in sporulation, motility, biofilm, and toxin production of Clostridioides difficile

    Journal of Global Antimicrobial Resistance, Vol. 33, pp. 328-336

  3. Using Technology to Teach/Learn Mathematics, How Are we as Teachers Fostering Mathematics Education Mobility?

    SEFI 2023 - 51st Annual Conference of the European Society for Engineering Education: Engineering Education for Sustainability, Proceedings

2022

  1. "In vitro" production of antibodies and their recombinant derivatives

    Immunotechnology "and its applications" (Ediciones de la Universidad de Oviedo), pp. 81-104

  2. A competitive assay for the detection of a 16-mer peptide from α1 chain of human collagen XI

    Talanta, Vol. 240

  3. Aptamers targeting a tumor-associated extracellular matrix component: The human mature collagen XIα1

    Analytica Chimica Acta, Vol. 1189

  4. B epitope mapping

    Immunotechnology "and its applications" (Ediciones de la Universidad de Oviedo), pp. 137-158

  5. Co-infection by classic MYXV and ha-MYXV in Iberian hare (Lepus granatensis) and European wild rabbit (Oryctolagus cuniculus algirus)

    Transboundary and Emerging Diseases, Vol. 69, Núm. 4, pp. 1684-1690

  6. Evaluation of Commercial Myxomatosis Vaccines against Recombinant Myxoma Virus (ha-MYXV) in Iberian Hare and Wild Rabbit

    Vaccines, Vol. 10, Núm. 3

  7. Humoral immunotherapy

    Immunotechnology "and its applications" (Ediciones de la Universidad de Oviedo), pp. 169-184

  8. Identification of a Novel Myxoma Virus C7-Like Host Range Factor That Enabled a Species Leap from Rabbits to Hares

    mBio, Vol. 13, Núm. 2

  9. Immunoassays

    Immunotechnology "and its applications" (Ediciones de la Universidad de Oviedo), pp. 117-136

  10. Prediction of B and T cell epitopes in proteins

    Immunotechnology "and its applications" (Ediciones de la Universidad de Oviedo), pp. 13-32

  11. Purification of antibodies and their recombinant derivatives

    Immunotechnology "and its applications" (Ediciones de la Universidad de Oviedo), pp. 105-116

  12. Spillover events of rabbit haemorrhagic disease virus 2 (recombinant GI.4P-GI.2) from Lagomorpha to Eurasian badger

    Transboundary and Emerging Diseases, Vol. 69, Núm. 3, pp. 1030-1045